These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22349420)

  • 1. Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.
    Lourenço AP; Vasques-Nóvoa F; Oliveira-Pinto J; Fontoura D; Roncon-Albuquerque R; Leite-Moreira AF
    Intensive Care Med; 2012 Jun; 38(6):1050-60. PubMed ID: 22349420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury.
    Persson BP; Rossi P; Weitzberg E; Oldner A
    Shock; 2009 Oct; 32(4):427-34. PubMed ID: 19197226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
    Fontoura D; Oliveira-Pinto J; Tavares-Silva M; Leite S; Vasques-Nóvoa F; Mendes-Ferreira P; Lourenço AP; Leite-Moreira AF
    Rev Port Cardiol; 2014 Apr; 33(4):213-22. PubMed ID: 24780128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
    Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
    Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
    Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
    Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of endothelin receptor antagonist, tezosentan, in tumour necrosis factor-alpha treated anaesthetized rats.
    Tabrizchi R; Ford CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):156-67. PubMed ID: 12595957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction.
    Clozel M; Qiu C; Qiu CS; Hess P; Clozel JP
    J Am Coll Cardiol; 2002 Jan; 39(1):142-7. PubMed ID: 11755300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs.
    Wang L; Zhu DM; Su X; Bai CX; Ware LB; Matthay MA
    Exp Lung Res; 2004; 30(1):31-42. PubMed ID: 14967602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Hill NS; Warburton RR; Pietras L; Klinger JR
    J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial.
    Denault AY; Pearl RG; Michler RE; Rao V; Tsui SS; Seitelberger R; Cromie M; Lindberg E; D'Armini AM
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1212-7. PubMed ID: 23523254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats.
    Yamaguchi T; Izumi Y; Yamazaki T; Nakamura Y; Sano S; Shiota M; Miura K; Iwao H; Yoshiyama M
    Osaka City Med J; 2015 Jun; 61(1):31-41. PubMed ID: 26434103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
    Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
    Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension.
    Geiger R; Treml B; Kleinsasser A; Neu N; Fischer V; Stein JI; Loeckinger A
    High Alt Med Biol; 2008; 9(3):223-7. PubMed ID: 18800959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
    Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H
    Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tezosentan increases nitric oxide signaling via enhanced hydrogen peroxide generation in lambs with surgically induced acute increases in pulmonary blood flow.
    Kumar S; Oishi PE; Rafikov R; Aggarwal S; Hou Y; Datar SA; Sharma S; Azakie A; Fineman JR; Black SM
    J Cell Biochem; 2013 Feb; 114(2):435-447. PubMed ID: 22961736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
    Lundgren J; Kylhammar D; Hedelin P; Rådegran G
    Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tezosentan, another selective selection for pulmonary hypertension, or not?
    Lorts A; Shanley TP
    Pediatr Crit Care Med; 2004 Nov; 5(6):586-8. PubMed ID: 15540040
    [No Abstract]   [Full Text] [Related]  

  • 19. Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.
    Urbanowicz W; Sogni P; Moreau R; Tazi KA; Barriere E; Poirel O; Martin A; Guimont MC; Cazals-Hatem D; Lebrec D
    Gut; 2004 Dec; 53(12):1844-9. PubMed ID: 15542526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.
    Lourenço AP; Roncon-Albuquerque R; Brás-Silva C; Faria B; Wieland J; Henriques-Coelho T; Correia-Pinto J; Leite-Moreira AF
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1587-94. PubMed ID: 16679394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.